"Tell me about your quality culture."
It's a question that strikes fear into many pharmaceutical executives. Not because they don't believe in quality. But because "quality culture" feels intangible—almost impossible to define.
Many organizations respond with mission statements proudly displayed on conference room walls. They talk about values. Integrity. Patient focus. Continuous improvement.
Those are all admirable. But FDA isn't inspecting the posters. They're inspecting the behaviors.
Because quality culture isn't what an organization says. It's what people do when no one is watching.
FDA Never Walks Into a Facility Looking for a Poster
Investigators don't arrive expecting employees to recite corporate values. Instead, they quietly observe hundreds of small interactions. Does an operator immediately report an error?
Or try to hide it? Does a supervisor encourage questions? Or punish people for slowing production? Does management delay a batch because something doesn't feel right?
Or look for reasons to release it anyway? Every one of these moments reveals culture.
Not policies. Not procedures. Culture.
Quality Culture Shows Up Long Before the Inspection
Many companies prepare extensively for FDA inspections. Documents become immaculate.
Conference rooms are polished. Teams rehearse responses. But culture cannot be rehearsed.
Within hours, investigators usually know whether quality is genuinely embedded or simply performed.
They notice:
Who answers questions confidently.
Who looks toward management before speaking.
Whether operators understand why procedures exist.
Whether investigations seem thoughtful—or rushed.
Whether employees appear comfortable raising concerns.
Culture leaks into everything.
Example One: The Missing Signature
An operator discovers they forgot to sign a manufacturing record several hours earlier.
In a weak quality culture, the first thought might be:
"Can I just sign it now and hope nobody notices?"
In a healthy quality culture, the thought is different:
"I need to report this immediately so we can document exactly what happened."
The paperwork is identical.
The mindset is not.
FDA recognizes that difference instantly.
Example Two: The Trending Deviation
A deviation has occurred four times in six months.
Management closes each investigation individually.
Each CAPA appears acceptable.
Yet no one asks the obvious question:
"Why does this keep happening?"
Organizations with strong quality cultures don't simply investigate events.
They investigate patterns.
They understand that recurring deviations are often symptoms of larger system weaknesses.
FDA increasingly expects the same.
Example Three: Production Pressure
It's Friday afternoon.
A critical batch is waiting for release.
One analytical result appears unusual.
Production wants to ship.
Quality wants more investigation.
In organizations with poor quality culture, commercial pressure often wins.
Someone explains away the data.
An assumption replaces evidence.
The batch moves.
In mature organizations, quality has the authority to stop the process.
Without fear.
Without retaliation.
Without apology.
FDA wants to see that independence.
People Should Never Fear Reporting Problems
One of the strongest indicators of quality culture is psychological safety.
Employees should feel comfortable saying:
"I made a mistake."
"I don't understand."
"This doesn't seem right."
"I think we should investigate further."
If employees fear punishment every time they report an issue, problems don't disappear.
They simply become invisible. Invisible problems eventually become FDA observations.
Or worse. Patient risks.
Quality Doesn't Belong to the Quality Unit
Perhaps the biggest misconception is believing Quality owns quality. It doesn't.
Manufacturing owns quality.
Engineering owns quality.
Supply Chain owns quality.
Validation owns quality.
Laboratories own quality.
Senior leadership owns quality.
The Quality Unit provides governance.
The organization creates culture.
FDA expects every function to understand how its daily decisions affect product quality and patient safety.
Leadership Builds—or Destroys—Culture Every Day
Quality culture is established less by speeches than by daily decisions. Employees notice everything. Did management investigate the concern thoroughly? Did they reward someone for speaking up? Did they postpone production because data was uncertain? Did executives attend Management Review prepared—or distracted? Did leadership invest in training before problems occurred? People learn what matters by watching leaders.
Not listening to them.
Data Integrity Is a Culture Issue
Organizations often view Data Integrity as a technical compliance requirement.
FDA increasingly views it as a cultural issue.
When employees backdate entries...
Share passwords...
Delete audit trails...
Delay recording information...
Or complete documentation from memory...
The problem is rarely software.
It's culture.
Healthy cultures value accurate data over convenient data. Because they understand that every data point represents a decision affecting patients.
Strong Quality Cultures Learn Faster
One characteristic separates exceptional pharmaceutical organizations from average ones:
They learn.
They don't become defensive after observations.
They become curious.
"What allowed this to happen?"
"What system failed?"
"What can we improve?"
"What early warning signs did we miss?"
Learning organizations become stronger after inspections. Defensive organizations repeat them.
So What Does FDA Really Mean by Quality Culture?
FDA isn't asking whether your employees can define quality culture. They're asking whether they live it.
They want to see organizations where:
Problems are surfaced early—not hidden.
Data is trusted because integrity is non-negotiable.
Investigations seek truth rather than blame.
CAPAs eliminate root causes instead of symptoms.
Leadership demonstrates that patient safety outweighs production pressure.
Employees understand that quality is everyone's responsibility—not just Quality's.
These organizations rarely become compliant by accident. They become compliant because thousands of daily decisions reinforce the same message:
Do the right thing—even when it's difficult.
That is what FDA means by quality culture.
Not a slogan.
Not a training module.
Not a framed set of values in the lobby.
A culture where every employee, every shift, every batch, and every decision consistently protects the patient.
And that's something no inspection can manufacture overnight.
QxP Vice President Christine Feaster is a 20+ year veteran in pharma quality assurance. Prior to joining QxP, Christine was a vice president of U.S. Pharmacopeia.
